BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol 2015; 7(26): 2648-2663 [PMID: 26609342 DOI: 10.4254/wjh.v7.i26.2648]
URL: https://www.wjgnet.com/1948-5182/full/v7/i26/2648.htm
Number Citing Articles
1
Luca Di Leo, Rolando Vegliante, Fabio Ciccarone, Illari Salvatori, Manuel Scimeca, Elena Bonanno, Andrea Sagnotta, Gian Luca Grazi, Katia Aquilano, Maria Rosa Ciriolo. Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53Oncogene 2019; 38(11): 1860 doi: 10.1038/s41388-018-0545-0
2
Hsi-Wen Yeh, Szu-Shuo Lee, Chieh-Yu Chang, Chun-Mei Hu, Yuh-Shan Jou. Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosisOncotarget 2017; 8(44): 77734 doi: 10.18632/oncotarget.20774
3
Jin‐Yu Sun, Xiao‐Yu Zhang, Yi‐Zhi Cao, Xiao Zhou, Jian Gu, Xiao‐Xin Mu. Diagnostic and prognostic value of circular RNAs in hepatocellular carcinomaJournal of Cellular and Molecular Medicine 2020; 24(10): 5438 doi: 10.1111/jcmm.15258
4
Xincheng Liu, Huohui Ou, Leyang Xiang, Xianghong Li, Yu Huang, Dinghua Yang. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinomaOncotarget 2017; 8(6): 10510 doi: 10.18632/oncotarget.14446
5
Rumeysa ÖZYURT, Mete OZKURT, Abdullah KARADAĞ, Cemile MERAL, Nılufer ERKASAP. Ceranib-2, HIF1-α gen ekspresyonunu inhibe eder ve HepG2 hücrelerinde apoptozu indüklerCukurova Medical Journal 2020; 45(4): 1318 doi: 10.17826/cumj.702236
6
Honghua Yan, Kyung Hee Jung, Juyoung Kim, Marufa Rumman, Myung Sook Oh, Soon-Sun Hong. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathwayBiomedicine & Pharmacotherapy 2018; 98: 134 doi: 10.1016/j.biopha.2017.12.043
7
Jens Hemmingsson, Jonas Högberg, Johan Mölne, Johanna Svensson, Peter Gjertsson, Magnus Rizell, Olof Henrikson, Peter Bernhardt. Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneitiesAdvances in Radiation Oncology 2018; 3(3): 439 doi: 10.1016/j.adro.2018.04.008
8
Zhijun Yu, Yinyin Li, Tao Han, Zhaozhe Liu. Demethylation of the HACE1 gene promoter inhibits the proliferation of human liver cancer cellsOncology Letters 2019;  doi: 10.3892/ol.2019.10139
9
Arthur Cassio de Lima Luna, Fabio Luis Forti. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferationMolecular and Cellular Biochemistry 2021;  doi: 10.1007/s11010-021-04167-5
10
Parisa Naeli, Mohammad Hossein Pourhanifeh, Mohammad Reza Karimzadeh, Zahra Shabaninejad, Ahmad Movahedpour, Hossein Tarrahimofrad, Hamid Reza Mirzaei, Hassan Hassani Bafrani, Amir Savardashtaki, Hamed Mirzaei, Michael R. Hamblin. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic roleCritical Reviews in Oncology/Hematology 2020; 145: 102854 doi: 10.1016/j.critrevonc.2019.102854
11
Zeng-Fa Gao, Yong-Na Wu, Zhong-Tian Bai, Lei Zhang, Qi Zhou, Xun Li. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significanceOncology Reports 2016; 36(6): 3427 doi: 10.3892/or.2016.5205
12
Matthias Van Haele, Tania Roskams. Hepatic Progenitor CellsGastroenterology Clinics of North America 2017; 46(2): 409 doi: 10.1016/j.gtc.2017.01.011
13
Leila Valanejad, Nikolai Timchenko. Akt-FoxO1 axis controls liver regenerationHepatology 2016; 63(5): 1424 doi: 10.1002/hep.28440
14
Na Ling, Xiaojun Zhou, Yubin Ji, Wenlan Li, Chenfeng Ji, Zheng Qi. Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing miceBiomedicine & Pharmacotherapy 2017; 91: 132 doi: 10.1016/j.biopha.2017.04.064
15
Ping-Hsing Tsai, Mong-Lien Wang, Jen-Hsuan Chang, Aliaksandr A. Yarmishyn, Phan Nguyen Nhi Nguyen, Wei Chen, Yueh Chien, Teh-Ia Huo, Chung-Yuan Mou, Shih-Hwa Chiou. Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem CellsACS Applied Materials & Interfaces 2019; 11(22): 19808 doi: 10.1021/acsami.9b04474
16
Nischal Koirala, Dola Das, Ehsan Fayazzadeh, Sanghamitra Sen, Andrew McClain, Judit E. Puskas, Judith A. Drazba, Gordon McLennan. Folic acid conjugated polymeric drug delivery vehicle for targeted cancer detection in hepatocellular carcinomaJournal of Biomedical Materials Research Part A 2019; 107(11): 2522 doi: 10.1002/jbm.a.36758
17
Firoz A. Dain Md Opo, Mohammed M. Rahman, Foysal Ahammad, Istiak Ahmed, Mohiuddin Ahmed Bhuiyan, Abdullah M. Asiri. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP proteinScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83626-x
18
Dan Yue, Xun Sun. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinomaCell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-0960-8
19
Young-Jun Jeon, Sanghee Kim, Ji Hee Kim, Ui Joung Youn, Sung-Suk Suh. The Comprehensive Roles of ATRANORIN, A Secondary Metabolite from the Antarctic Lichen Stereocaulon caespitosum, in HCC TumorigenesisMolecules 2019; 24(7): 1414 doi: 10.3390/molecules24071414
20
Ruchi Jain, Josh P. Frederick, Eric Y. Huang, Kristine E. Burke, David M. Mauger, Elizaveta A. Andrianova, Sam J. Farlow, Summar Siddiqui, Jeffrey Pimentel, Kahlin Cheung-Ong, Kristine M. McKinney, Caroline Köhrer, Melissa J. Moore, Tirtha Chakraborty. MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-DestructNucleic Acid Therapeutics 2018; 28(5): 285 doi: 10.1089/nat.2018.0734
21
Changwen Bo, Na Li, Xiuli Li, Xianwei Liang, Yonghui An. Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinomaHuman Cell 2016; 29(4): 141 doi: 10.1007/s13577-016-0140-z
22
J Gowthami, N Gururaj, V Mahalakshmi, R Sathya, TR Sabarinath, DaffneyMano Doss. Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic reviewJournal of Oral and Maxillofacial Pathology 2020; 24(2): 293 doi: 10.4103/jomfp.JOMFP_348_19
23
Abu Bakar Hafeez Bhatti, Faisal Saud Dar, Anum Waheed, Kashif Shafique, Faisal Sultan, Najmul Hassan Shah. Hepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5942306
24
Sarah Scollon, Amanda Knoth Anglin, Martha Thomas, Joyce T. Turner, Kami Wolfe Schneider. A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition SyndromesJournal of Genetic Counseling 2017; 26(3): 387 doi: 10.1007/s10897-017-0077-8
25
Sabine Gerum, Alexandra D Jensen, Falk Roeder. Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-reviewWorld Journal of Gastrointestinal Oncology 2019; 11(5): 367-376 doi: 10.4251/wjgo.v11.i5.367
26
Wenqing Tang, Zhiying Zhao, Chen Wang, Tao Ye, Biwei Yang. Molecular design and optimization of hepatic cancer SLP76‐derived PLCγ1 SH3‐binding peptide with the systematic N‐substitution of peptide PXXP motifJournal of Molecular Recognition 2019; 32(12) doi: 10.1002/jmr.2806
27
Brenda de Oliveira da Silva, Luciane Carla Alberici, Letícia Ferreira Ramos, Caio Mateus Silva, Marina Bonfogo da Silveira, Carlos R.P. Dechant, Scott L. Friedman, Kumiko Koibuchi Sakane, Letícia Rocha Gonçalves, Karen C.M. Moraes. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1–7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolismThe International Journal of Biochemistry & Cell Biology 2018; 98: 137 doi: 10.1016/j.biocel.2018.02.018
28
Pengcheng Hu, Dengfeng Cheng, Tao Huang, Anna B. Banizs, Jie Xiao, Guobing Liu, Quan Chen, Yuenan Wang, Jiang He, Hongcheng Shi. Evaluation of Novel 64Cu-Labeled Theranostic Gadolinium-Based Nanoprobes in HepG2 Tumor-Bearing Nude MiceNanoscale Research Letters 2017; 12(1) doi: 10.1186/s11671-017-2292-5
29
Carole Sourbier. Plasma HSP90α and liver cancer: a potential biomarker?EBioMedicine 2017; 25: 7 doi: 10.1016/j.ebiom.2017.10.012
30
Javier A García-Vilas, Miguel Ángel Medina. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implicationsWorld Journal of Gastroenterology 2018; 24(33): 3695-3708 doi: 10.3748/wjg.v24.i33.3695
31
Guiliang Wang, Yan Liu, Shu-feng Zhou, Ping Qiu, Linfang Xu, Ping Wen, Jianbo Wen, Xianzhong Xiao. Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic reviewHepatology International 2016; 10(3): 501 doi: 10.1007/s12072-015-9700-7
32
Qi Wang, Xiangyu Zhang, Hongze Liao, Ying Sun, Li Ding, Yanwei Teng, Wei-Hong Zhu, Zhirong Zhang, Yourong Duan. Multifunctional Shell-Core Nanoparticles for Treatment of Multidrug Resistance Hepatocellular CarcinomaAdvanced Functional Materials 2018; 28(14): 1706124 doi: 10.1002/adfm.201706124
33
Sukeshi Patel Arora, Gabor Liposits, Susan Caird, Richard F. Dunne, Gordon Taylor Moffat, David Okonji, Maria Grazia Rodriquenz, Divyanshu Dua, Efrat Dotan. Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric OncologyJournal of Geriatric Oncology 2020; 11(4): 557 doi: 10.1016/j.jgo.2019.10.007
34
Yong Zhou, Wen-Yang Shi, Wei He, Zhao-Wen Yan, Man-Hua Liu, Jing Chen, Yun-Sheng Yang, Yin-Qi Wang, Guo-Qiang Chen, Ying Huang. FAM122A supports the growth of hepatocellular carcinoma cells and its deletion enhances Doxorubicin-induced cytotoxicityExperimental Cell Research 2020; 387(1): 111714 doi: 10.1016/j.yexcr.2019.111714
35
Susan L Stewart, Sandy L Kwong, Christopher L Bowlus, Tung T Nguyen, Annette E Maxwell, Roshan Bastani, Eric W Chak, Moon S Chen Jr. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012World Journal of Gastroenterology 2016; 22(38): 8584-8595 doi: 10.3748/wjg.v22.i38.8584
36
Zhouhua Hou, Jun Quan. Hepatitis B virus X protein increases microRNA-21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathwayMolecular Medicine Reports 2017; 15(5): 3285 doi: 10.3892/mmr.2017.6363
37
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experienceAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 67 doi: 10.16931/1995-5464.2020267-76
38
Zhangang Xiao, Jing Shen, Lin Zhang, Mingxing Li, Wei Hu, Chihin Cho. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (Review)Oncology Letters 2018;  doi: 10.3892/ol.2018.7758
39
Marie-Hélène Wasmer, Philippe Krebs. The Role of IL-33-Dependent Inflammation in the Tumor MicroenvironmentFrontiers in Immunology 2017; 7 doi: 10.3389/fimmu.2016.00682
40
Xiaoxin Jin, Lifeng Cai, Changfa Wang, Xiaofeng Deng, Shengen Yi, Zhao Lei, Qiangsheng Xiao, Hongbo Xu, Hongwu Luo, Jichun Sun. CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3Cell Death & Disease 2018; 9(3) doi: 10.1038/s41419-018-0350-2
41
Jaewoo Hong, Soohyun Kim, P. Charles Lin. Interleukin-33 and ST2 Signaling in Tumor MicroenvironmentJournal of Interferon & Cytokine Research 2019; 39(1): 61 doi: 10.1089/jir.2018.0044
42
Chu Chen, Tao Lou. Hypoxia inducible factors in hepatocellular carcinomaOncotarget 2017; 8(28): 46691 doi: 10.18632/oncotarget.17358
43
Shima Ghavimi, Tehila Apfel, Hamed Azimi, Alana Persaud, Nikolaos T. Pyrsopoulos. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future OptionsJournal of Clinical and Translational Hepatology 2020; 8(2): 168 doi: 10.14218/JCTH.2020.00001
44
Junya Matsushita, Takehiro Suzuki, Kazuyuki Okamura, Gaku Ichihara, Keiko Nohara. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changesEnvironmental Health and Preventive Medicine 2020; 25(1) doi: 10.1186/s12199-020-00871-8
45
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseasesAdvanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
46
Vitoantonio Bevilacqua, Antonio Brunetti, Gianpaolo Francesco Trotta, Leonarda Carnimeo, Francescomaria Marino, Vito Alberotanza, Arnaldo Scardapane. Deep Learning and Neural Networks2020; : 353 doi: 10.4018/978-1-7998-0414-7.ch021
47
Tingting Sun, Jinfeng Han, Shi Liu, Xin Wang, Zhi Yuan Wang, Zhigang Xie. Tailor-Made Semiconducting Polymers for Second Near-Infrared Photothermal Therapy of Orthotopic Liver CancerACS Nano 2019; 13(6): 7345 doi: 10.1021/acsnano.9b03910
48
Yu-Cheng Liu, Daniel Stanley Tan, Jyh-Cheng Chen, Wen-Huang Cheng, Kai-Lung Hua. Segmenting Hepatic Lesions Using Residual Attention U-Net with an Adaptive Weighted Dice Loss2019 IEEE International Conference on Image Processing (ICIP) 2019; : 3322 doi: 10.1109/ICIP.2019.8803471
49
Anahid Amiri, Florian D. Hastert, Christian Dietz. Carcinomas with Occult Metastasis Potential: Diagnosis/Prognosis Accuracy Improvement by Means of Force SpectroscopyAdvanced Biosystems 2020; 4(7): 2000042 doi: 10.1002/adbi.202000042
50
Payal Deepak, Rajinikanth Siddalingam, Praveen Kumar, Sneha Anand, Sunita Thakur, Balasubramaniam Jagdish, Shweta Jaiswal. Gene based nanocarrier delivery for the treatment of hepatocellular carcinomaJournal of Drug Delivery Science and Technology 2020; 59: 101837 doi: 10.1016/j.jddst.2020.101837
51
Saimila Momin, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignanciesDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 253 doi: 10.1007/978-981-15-5471-1_15
52
Shivanand P. Gajare, Prakash A. Bansode, Pradnya V. Patil, Audumbar D. Patil, Dattaprasad M. Pore, Kailas D. Sonawane, Maruti J. Dhanavade, Vishwajeet M. Khot, Gajanan S. Rashinkar. Anticancer, Antibacterial and Hyperthermia Studies of a Caffeine‐Based N ‐Heterocyclic Carbene Silver Complex Anchored on Magnetic Nanoparticles ChemistrySelect 2021; 6(9): 1958 doi: 10.1002/slct.202004139
53
Pengcheng Hu, Zhequan Fu, Guobing Liu, Hui Tan, Jie Xiao, Hongcheng Shi, Dengfeng Cheng. Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular CarcinomaFrontiers in Bioengineering and Biotechnology 2019; 7 doi: 10.3389/fbioe.2019.00368
54
Hua Ding, Zhi-Hua Ye, Dong-Yue Wen, Xiao-Liang Huang, Chu-Mei Zeng, Jie Mo, Yi-Qiang Jiang, Jian-Jun Li, Xiao-Yong Cai, Hong Yang, Gang Chen. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significanceMolecular Medicine Reports 2017; 16(4): 5393 doi: 10.3892/mmr.2017.7275
55
Pooja Siniprasad, Bhagyalakshmi Nair, Vaisali Balasubramaniam, Prashanth Sadanandan, Puliyapally Krishnan Namboori, Lekshmi Reghu Nath. Evaluation of Kaempferol as AKT Dependent mTOR Regulator via Targeting FKBP-12 in Hepatocellular Carcinoma: An In silico ApproachLetters in Drug Design & Discovery 2020; 17(11): 1401 doi: 10.2174/1570180817999200623115703
56
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infectionWorld Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
57
Hsin-Yi Lee, Chi-Kuan Chen, Chun-Ming Ho, Szu-Shuo Lee, Chieh-Yu Chang, Kuan-Ju Chen, Yuh-Shan Jou. EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinomaOncotarget 2018; 9(17): 13193 doi: 10.18632/oncotarget.24149
58
Zhong-dong Wang, Fan-yong Qu, Yuan-yuan Chen, Zhang-shen Ran, Hai-yan Liu, Hai-dong Zhang. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cellsJournal of Zhejiang University-SCIENCE B 2017; 18(1): 27 doi: 10.1631/jzus.B1600205
59
Vitoantonio Bevilacqua, Antonio Brunetti, Gianpaolo Francesco Trotta, Leonarda Carnimeo, Francescomaria Marino, Vito Alberotanza, Arnaldo Scardapane. A Deep Learning Approach for Hepatocellular Carcinoma GradingInternational Journal of Computer Vision and Image Processing 2017; 7(2): 1 doi: 10.4018/IJCVIP.2017040101
60
Yan Wang, Mengjing Sun, Jibin Liu, Ying Liu, Chunyi Jiang, Huijun Zhu, Wei Wang, Yao Wang. FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinomaOncology Letters 2019;  doi: 10.3892/ol.2019.11183
61
Sejal S. Shah, Tsung-Teh Wu, Michael S. Torbenson, Vishal S. Chandan. Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfallHuman Pathology 2017; 64: 13 doi: 10.1016/j.humpath.2016.12.029
62
Ning Li, Yuting Jiang, Rosalie Plantefève, Francois Michaud, Zeynab Nosrati, Charles Tremblay, Katayoun Saatchi, Urs O. Häfeli, Samuel Kadoury, Gerald Moran, Florian Joly, Sylvain Martel, Gilles Soulez. Magnetic Resonance Navigation for Targeted Embolization in a Two-Level Bifurcation PhantomAnnals of Biomedical Engineering 2019; 47(12): 2402 doi: 10.1007/s10439-019-02317-x
63
Ahmed Mahmoud, Kellee Slater. Hepatocellular Carcinoma Misdiagnosed as a Liver Abscess – A Story of Misdiagnosis and Long-Term Malignant Disease ControlCureus 2021;  doi: 10.7759/cureus.12636
64
Weiyue Li, Xiang Xiao, Xiaodan Li, Yikai Xu, Lichao Ma, Liuji Guo, Chenggong Yan, Yuankui Wu. Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging ExperimentsContrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9169072
65
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Paprottka, Enrico N. De Toni, Falk Roeder. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver diseaseRadiation Oncology 2018; 13(1) doi: 10.1186/s13014-018-1048-4
66
Emmeline Ha, Frederic Kim, Janice Blanchard, Hee-Soon Juon. Prevalence of Chronic Hepatitis B and C Infection in Mongolian Immigrants in the Washington, District of Columbia, Metropolitan Area, 2016–2017Preventing Chronic Disease 2019; 16 doi: 10.5888/pcd16.180104
67
Gian Piero Guerrini, Domenico Pinelli, Elena Marini, Vittorio Corno, Michela Guizzetti, Marco Zambelli, Alessandro Aluffi, Lisa Lincini, Stefano Fagiuoli, Alessandro Lucianetti, Michele Colledan. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver TransplantationProgress in Transplantation 2018; 28(1): 63 doi: 10.1177/1526924817746686
68
Tawatchai Apidechkul. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern ThailandBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3747-3
69
Ishaan Vohra, Bashar Attar, Vatsala Katiyar, Pedro Palacios, Tejinder Randhawa, Muhammad Arslan Baig, Estefania Flores, Yuchen Wang, Hemant Mutneja, Sachit Sharma, Prashanth Lingamneni, Muhammad Zain Farooq, Naveen Bhaskaran, Seema Gandhi, Gijo Vettiankal, Melchor Demetria. Evaluation of Ferritin and Transferrin Ratio as a Prognostic Marker for Hepatocellular CarcinomaJournal of Gastrointestinal Cancer 2021; 52(1): 201 doi: 10.1007/s12029-020-00373-4
70
Roland Böttger, Griffin Pauli, Po-Han Chao, Nojoud AL Fayez, Lukas Hohenwarter, Shyh-Dar Li. Lipid-based nanoparticle technologies for liver targetingAdvanced Drug Delivery Reviews 2020; : 79 doi: 10.1016/j.addr.2020.06.017
71
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosisArab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
72
Nikolaus Berndt, Antje Egners, Guido Mastrobuoni, Olga Vvedenskaya, Athanassios Fragoulis, Aurélien Dugourd, Sascha Bulik, Matthias Pietzke, Chris Bielow, Rob van Gassel, Steven W. Olde Damink, Merve Erdem, Julio Saez-Rodriguez, Hermann-Georg Holzhütter, Stefan Kempa, Thorsten Cramer. Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancerBritish Journal of Cancer 2020; 122(2): 233 doi: 10.1038/s41416-019-0659-3
73
Wei Dong, Zhi-hui Dai, Fu-chen Liu, Xing-gang Guo, Chun-mei Ge, Jin Ding, Hui Liu, Fu Yang. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 productionEBioMedicine 2019; 45: 155 doi: 10.1016/j.ebiom.2019.06.030
74
Marco Di Paola, Alessandra Quarta, Francesco Conversano, Enzo Antonio Sbenaglia, Simona Bettini, Ludovico Valli, Giuseppe Gigli, Sergio Casciaro. Human Hepatocarcinoma Cell Targeting by Glypican-3 Ligand Peptide Functionalized Silica Nanoparticles: Implications for Ultrasound Molecular ImagingLangmuir 2017; 33(18): 4490 doi: 10.1021/acs.langmuir.7b00327
75
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Marius Paprottka, Enrico N De Toni, Falk Roeder. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment settingStrahlentherapie und Onkologie 2020; 196(4): 334 doi: 10.1007/s00066-019-01540-8
76
Lipeng Qiu, Qi Tang, Guohui Li, Keping Chen. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinomaLife Sciences 2017; 191: 273 doi: 10.1016/j.lfs.2017.10.007
77
Miao-Mei Yu, Yue-Hua Feng, Lu Zheng, Jun Zhang, Guang-Hua Luo. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cellsWorld Journal of Gastroenterology 2019; 25(10): 1210-1223 doi: 10.3748/wjg.v25.i10.1210
78
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewPanminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
79
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinomaExpert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
80
Yulia A. Nevzorova, Johannes Grossmann, Christian Trautwein. Anti-tumorigenic and anti-angiogenic effects of natural conifer Abies sibirica terpenoids in vivo and in vitroBiomedicine & Pharmacotherapy 2017; 89: 386 doi: 10.1016/j.biopha.2017.02.035
81
Anil Kumar Chauhan, Monika Bhardwaj, Pankaj Kumar Chaturvedi. Molecular Diagnostics in Cancer Patients2019; : 293 doi: 10.1007/978-981-13-5877-7_17
82
Yunbin Zhang, Jiang Xu, Ning Zhang, Ming Chen, Hua Wang, Di Zhu. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignanciesCancer Letters 2019; 458: 123 doi: 10.1016/j.canlet.2019.05.017
83
Hyosun Tak, Hoin Kang, Eunbyul Ji, Youlim Hong, Wook Kim, Eun Kyung Lee. Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinomaBiochemical and Biophysical Research Communications 2018; 497(4): 1117 doi: 10.1016/j.bbrc.2018.02.189
84
Heba H. Sokkar, Ahmed S. Abo Dena, Noha Ahmed Mahana, Abeer Badr. Artichoke extracts in cancer therapy: do the extraction conditions affect the anticancer activity?Future Journal of Pharmaceutical Sciences 2020; 6(1) doi: 10.1186/s43094-020-00088-0
85
Maria Cristina Bonferoni, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri, Paolo Giunchedi. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-TargetingNanomaterials 2020; 10(5): 870 doi: 10.3390/nano10050870
86
Daoshan Zheng, Cecilia Williams, Jeremy A. Vold, Justin H. Nguyen, Denise M. Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin, Zhaoyu Li. Regulation of sex hormone receptors in sexual dimorphism of human cancersCancer Letters 2018; 438: 24 doi: 10.1016/j.canlet.2018.09.001
87
Dong Ik Cha, Kyung Mi Jang, Seong Hyun Kim, Tae Wook Kang, Kyoung Doo Song. Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imagingEuropean Radiology 2017; 27(10): 4394 doi: 10.1007/s00330-017-4804-1
88
Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. Bullock, Craig L. Slingluff, Osama E. Rahma. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?Cancer Immunology, Immunotherapy 2018; 67(2): 161 doi: 10.1007/s00262-017-2082-z
89
Chih-Tien Chen, Hsiang-Lin Lee, Hui-Ling Chiou, Chia-Hsuan Chou, Po-Hui Wang, Shun-Fa Yang, Ying-Erh Chou, Pavel Strnad. Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma developmentPLOS ONE 2018; 13(6): e0198967 doi: 10.1371/journal.pone.0198967
90
Dongqiang Song, Beili Xu, Dongmin Shi, Shuyu Li, Yu Cai. S100A6 promotes proliferation and migration of HepG2 cells via increased ubiquitin-dependent degradation of p53Open Medicine 2020; 15(1): 317 doi: 10.1515/med-2020-0101
91
Hany A. Omar, Dana M. Zaher, Vunnam Srinivasulu, Fatema Hersi, Hamadeh Tarazi, Taleb H. Al-Tel. Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinomaEuropean Journal of Medicinal Chemistry 2017; 139: 804 doi: 10.1016/j.ejmech.2017.08.054
92
Kuo-Shyang Jeng, Chi-Juei Jeng, Wen-Juei Jeng, Chiung-Fang Chang, I-Shyan Sheen. Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinomaOncology Letters 2017; 14(2): 1905 doi: 10.3892/ol.2017.6396
93
Brittany Dewdney, Alexandra Roberts, Liang Qiao, Jacob George, Lionel Hebbard. A Sweet Connection? Fructose’s Role in Hepatocellular CarcinomaBiomolecules 2020; 10(4): 496 doi: 10.3390/biom10040496
94
Xiukun Fei, Peipei Zhang, Yu Pan, Yuanyuan Liu. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing KinaseYonsei Medical Journal 2020; 61(6): 460 doi: 10.3349/ymj.2020.61.6.460
95
Lanxia Liu, Hai Wang, Qi Liu, Mingli Duan, Xia Dong, Dunwan Zhu, Yingjun Zhu, Xigang Leng. Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenograftsJournal of Biomedical Materials Research Part A 2016; 104(10): 2394 doi: 10.1002/jbm.a.35775
96
Da Xu, Jessica Qiuhua Sheng, Paul Jen-Hwa Hu, Ting Shuo Huang, Wei-Chen Lee. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variablesJournal of Biomedical Informatics 2019; 96: 103237 doi: 10.1016/j.jbi.2019.103237
97
Divya R, Radha P. An Optimized HCC Recurrence Prediction Using APO Algorithm Multiple Time Series Clinical Liver Cancer DatasetJournal of Medical Systems 2019; 43(7) doi: 10.1007/s10916-019-1265-x
98
Zaki A. Sherif, Seyed Mehdi Nouraie, Edward Lee, Farshad Aduli, Hassan Brim, Hassan Ashktorab. Trends in the Incidence of Hepatocellular Carcinoma in Washington DC: A Single Institutional Cohort Study (1959–2013)Journal of the National Medical Association 2021;  doi: 10.1016/j.jnma.2021.02.001
99
Margherita Maioli, Valentina Basoli, Paola Carta, Davide Fabbri, Maria Antonietta Dettori, Sara Cruciani, Pier Andrea Serra, Giovanna Delogu, Andrea Motta. Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cellsPLOS ONE 2018; 13(2): e0192178 doi: 10.1371/journal.pone.0192178
100
Rafiqatul Khairi, Zuherman Rustam, Suarsih Utama. Possibilistics C-Means (PCM) Algorithm for the Hepatocellular Carcinoma (HCC) ClassificationIOP Conference Series: Materials Science and Engineering 2019; 546: 052038 doi: 10.1088/1757-899X/546/5/052038
101
Angel Juarez-Flores, Marco José. Multivariate Entropy Characterizes the Gene Expression and Protein-Protein Networks in Four Types of CancerEntropy 2018; 20(3): 154 doi: 10.3390/e20030154
102
Hsin-An Chen, Chi-Cheng Li, Yu-Jung Lin, Tso-Fu Wang, Ming-Cheng Chen, Yen-Hao Su, Yu-Lan Yeh, V. Vijaya Padma, Po-Hsiang Liao, Chih-Yang Huang. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cellsAging 2021; 13(8): 12046 doi: 10.18632/aging.202908
103
Xiaofeng Hang, Zhiqin Wu, Kaijian Chu, Guanzhen Yu, Haoran Peng, Haiguang Xin, Xiaohui Miao, Junxue Wang, Wensheng Xu. Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patientsTumor Biology 2016; 37(11): 15079 doi: 10.1007/s13277-016-5302-9
104
Tracy Huang, Senlin Xu, Rucha Deo, An Ma, Hongzhi Li, Ke Ma, Xiaoxian Gan. Targeting the Ca2+/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cellsBiochemical and Biophysical Research Communications 2019; 508(4): 1227 doi: 10.1016/j.bbrc.2018.12.012
105
Haijun Wang, Maria Carmenza Mejia, Sandra J. Gonzalez, Roger J. Zoorob, Weiwen Chai, Xianglin L. Du. Cancer incidence and survival trends among infants in the United States from 1975 to 2014Pediatric Blood & Cancer 2021; 68(4) doi: 10.1002/pbc.28917
106
David F. Pinal-García, Carlos M. Nuño-Guzmán, Audrey Gómez-Abarca, Jorge L. Corona, Ismael Espejo. Spontaneous Rupture of Hepatocellular Carcinoma in a Young Patient with Fatal OutcomeCase Reports in Gastroenterology 2018; 12(1): 19 doi: 10.1159/000486193
107
Jean-Pierre Gillet, Jesper B. Andersen, James P. Madigan, Sudhir Varma, Rachel K. Bagni, Katie Powell, William E. Burgan, Chung-Pu Wu, Anna Maria Calcagno, Suresh V. Ambudkar, Snorri S. Thorgeirsson, Michael M. Gottesman. A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment StrategyMolecular Pharmacology 2016; 89(2): 263 doi: 10.1124/mol.115.101360